Kailera Therapeutics Secures $625 Million in Landmark Biotech IPO, Igniting Competition in the Obesity Drug Market
admin Kailera Therapeutics, a formidable new entrant in the pharmaceutical landscape poised to challenge industry giants...
biotech
A Rare Cancer and the Clinical Trial That Saved Her Life
Adrienne Skinner’s journey through a harrowing cancer diagnosis to a life-affirming recovery stands as a...
FDA Plans Advisory Committee Meetings on Peptide Reclassification Amidst Political Scrutiny and Calls for Regulatory Clarity
The Food and Drug Administration (FDA) is set to convene a series of advisory committee...
Eli Lilly’s Foundayo Faces Post-Approval FDA Scrutiny Over Liver Safety Data from Ongoing Diabetes Trial.
Eli Lilly’s newly approved oral obesity medication, Foundayo (orforglipron), has been subjected to significant post-market...
Terremoto raises $108M to pursue development of drugs targeting AKT
California-based Terremoto Biosciences has successfully closed a substantial $75 million Series A financing round, positioning...
Cancer Statistics 2026 Report Reveals Historic Survival Gains Driven by Immunotherapy, Highlights Persistent Disparities
The American Cancer Society’s landmark Cancer Statistics 2026 report paints a compelling picture of both...
Beeline Medicines Debuts with $300 Million Funding and Bristol Myers Squibb Pipeline to Advance Precision Therapies for Autoimmune Diseases.
Emerging from stealth on Wednesday, April 15, 2026, Beeline Medicines announced its official launch, fortified...
The Silent Epidemic: Understanding and Combating the Alarming Rise of Colorectal Cancer in Younger Adults.
Colorectal cancer (CRC), once predominantly associated with older age, is experiencing a disturbing surge among...
A New Era in Cancer Care: Immunotherapy Summit Unveils Breakthroughs from Long-Term Survival to AI-Driven Cures
The IO360° Summit, held in Boston in February 2026, served as a pivotal gathering for...
Johnson & Johnson Exceeds Q1 Expectations with Robust Oncology Growth, Navigating Immunology Shifts
Johnson & Johnson, the global healthcare behemoth, announced a stellar first-quarter performance for 2026, significantly...
